Regeneron and Sanofi are cutting the price they charge pharmacy benefit manager Express Scripts for their cholesterol medicine, Praluent. In return, Express Scripts will remove almost all restrictions on the medicine, and make it cheaper for patients.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2018/05/01/lets-make-a-deal-drugmakers-try-to-reignite-a-dormant-cholesterol-drug-with-price-cut/
via IFTTT
No comments:
Post a Comment